XML 22 R8.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Total Parent Equity
Total Parent Equity
Cumulative Effect, Period of Adoption, Adjustment
Non- controlling Interests in Subsidiaries
Beginning balance (in shares) at Dec. 31, 2019     145,378,158              
Beginning balance at Dec. 31, 2019 $ 3,695,500 $ (11,432) $ 145,378 $ 98,777 $ (1,141,308) $ 4,571,860 $ (11,432) $ 3,674,707 $ (11,432) $ 20,793
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) (29,102)         (29,102)   (29,102)    
Other comprehensive (loss) income, net of tax 104,806       104,806     104,806    
Cash dividends declared (456,469)         (456,469)   (456,469)    
Share-based awards exercised, including tax benefit (in shares)     112,621              
Share-based awards exercised, including tax benefit (4,120)   $ 113 (4,233)       (4,120)    
Share-based compensation 22,621     22,621       22,621    
Purchase of stock (in shares)     (1,136,444)              
Purchase of stock (96,215)   $ (1,137)     (95,078)   (96,215)    
Noncontrolling interest activities (7,586)                 (7,586)
Ending balance (in shares) at Dec. 31, 2020     144,354,335              
Ending balance at Dec. 31, 2020 $ 3,218,003 $ 6,223 $ 144,354 117,165 (1,036,502) 3,979,779 $ 6,223 3,204,796 $ 6,223 13,207
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Accounting Standards Update [Extensible List] Accounting Standards Update 2019-12 [Member]                  
Net income (loss) $ 898,790         898,790   898,790    
Other comprehensive (loss) income, net of tax 178,763       178,763     178,763    
Cash dividends declared (467,482)         (467,482)   (467,482)    
Share-based awards exercised, including tax benefit (in shares)     440,667              
Share-based awards exercised, including tax benefit (22,346)   $ 441 (22,787)       (22,346)    
Share-based compensation 25,597     25,597       25,597    
Purchase of stock (in shares)     (2,614,319)              
Purchase of stock (333,599)   $ (2,614)     (330,985)   (333,599)    
Noncontrolling interest activities (659)                 (659)
Ending balance (in shares) at Dec. 31, 2021     142,180,683              
Ending balance at Dec. 31, 2021 3,503,290   $ 142,181 119,975 (857,739) 4,086,325   3,490,742   12,548
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) 1,182,701         1,182,701   1,182,701    
Other comprehensive (loss) income, net of tax (174,803)       (174,803)     (174,803)    
Cash dividends declared (506,232)         (506,232)   (506,232)    
Share-based awards exercised, including tax benefit (in shares)     333,185              
Share-based awards exercised, including tax benefit (17,377)   $ 332 (17,709)       (17,377)    
Share-based compensation 38,058     38,058       38,058    
Purchase of stock (in shares)     (1,572,219)              
Purchase of stock (222,726)   $ (1,572)     (221,154)   (222,726)    
Noncontrolling interest activities 1,536                 1,536
Ending balance (in shares) at Dec. 31, 2022     140,941,649              
Ending balance at Dec. 31, 2022 $ 3,804,447   $ 140,941 $ 140,324 $ (1,032,542) $ 4,541,640   $ 3,790,363   $ 14,084